Lemonade stock has delivered a very large 3 year return of 252.0%, yet the broader valuation checks currently flag the shares as expensive rather than a clear bargain. Recent share price swings sit against a low value score and an overvalued read on market multiples, which together raise questions about how much good news is already reflected in the price.

• Over the last 3 years, Lemonade has returned 252.0%, which puts extra focus on whether the current share price leaves much room for error.
• Expectations that the business can scale its insurance platform and improve unit economics may support the current valuation, while ongoing losses and the need to fund growth remain key risks for how investors price the stock.
• Lemonade passes 0 of 6 valuation checks, which suggests it does not screen as a clear bargain on Simply Wall St's broader framework, including the value score.

The issue now is whether Lemonade's current valuation still offers a reasonable trade off between its growth ambitions and the risks around profitability and capital needs.

Is Lemonade Getting Expensive on Sales?

For a business like Lemonade that is still working towards consistent profitability, investors often look to the P/S ratio to see how the market is valuing each dollar of revenue. Lemonade currently trades on a P/S of 6.4x, compared with an Insurance industry average of about 1.2x and a peer average of roughly 1.3x, so the stock is priced at a sizeable premium to many insurers on this measure.

The fair P/S ratio from Simply Wall St’s model is 1.8x, which is much lower than the current 6.4x. Because the gap is very wide, the model is heavily penalising Lemonade for its recent losses, risk profile and the quality of its revenue. This figure is therefore better seen as a strong warning signal than a precise target. Even allowing for those limitations, the numbers indicate that a lot of optimism around Lemonade’s growth ambitions is already reflected in the P/S multiple.

Overall, Lemonade appears overvalued on the P/S multiple compared with both its tailored fair ratio and wider insurance peers.

The Lemonade Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Lemonade act as the link between the current valuation puzzle and the specific expectations that would need to play out on growth, margins and earnings for the stock to be worth materially more or less than today's price, and they sit on the Community page. Instead of giving a single figure like a P/S based fair value, they lay out the future path those numbers rely on so you can watch whether Lemonade's progress lines up with that story over time.

Community narratives on Lemonade sit far apart, with one side focused on an AI driven inflection in profitability and the other on execution and risk limits to that story.

Bull case: 23% undervalued

"The company's embedded data advantage and end-to-end AI integration not only improve underwriting and claims but create a self-reinforcing AI flywheel, enabling ongoing structural reductions in operating expenses and loss adjustment expenses..."

Bear case: 14% overvalued

"The company's lower reliance on quota share reinsurance increases revenue retention in the near term, but also exposes Lemonade to higher risk from catastrophic events and volatility in claims costs, which could negatively impact gross profit and net margins..."

Do you think there's more to the story for Lemonade? Head over to our Community to see what others are saying!

The Bottom Line

For Lemonade, the market multiple view points to an overvalued stock, with a sizeable gap between current pricing and the tailored fair ratio that is heavily penalising ongoing losses and risk. That kind of premium can persist, but it leaves little room if sentiment cools or execution on the insurance platform slips. The crux from here is whether Lemonade can improve unit economics and move meaningfully closer to sustainable profitability fast enough to keep justifying or eventually grow into this elevated valuation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.